JP2023553642A5 - - Google Patents

Info

Publication number
JP2023553642A5
JP2023553642A5 JP2023536038A JP2023536038A JP2023553642A5 JP 2023553642 A5 JP2023553642 A5 JP 2023553642A5 JP 2023536038 A JP2023536038 A JP 2023536038A JP 2023536038 A JP2023536038 A JP 2023536038A JP 2023553642 A5 JP2023553642 A5 JP 2023553642A5
Authority
JP
Japan
Prior art keywords
pain
acid ester
formulation
formulation according
dicarboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023536038A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023553642A (ja
JP7837335B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/061872 external-priority patent/WO2022130288A1/en
Publication of JP2023553642A publication Critical patent/JP2023553642A/ja
Publication of JP2023553642A5 publication Critical patent/JP2023553642A5/ja
Application granted granted Critical
Publication of JP7837335B2 publication Critical patent/JP7837335B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023536038A 2020-12-16 2021-12-16 鎮痛効果を誘導するためのジカルボン酸エステル Active JP7837335B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063126387P 2020-12-16 2020-12-16
US63/126,387 2020-12-16
PCT/IB2021/061872 WO2022130288A1 (en) 2020-12-16 2021-12-16 Dicarboxylic acid esters for inducing an analgesic effect

Publications (3)

Publication Number Publication Date
JP2023553642A JP2023553642A (ja) 2023-12-25
JP2023553642A5 true JP2023553642A5 (enExample) 2024-10-28
JP7837335B2 JP7837335B2 (ja) 2026-03-30

Family

ID=81942874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023536038A Active JP7837335B2 (ja) 2020-12-16 2021-12-16 鎮痛効果を誘導するためのジカルボン酸エステル

Country Status (12)

Country Link
US (1) US11911358B2 (enExample)
EP (1) EP4262779A4 (enExample)
JP (1) JP7837335B2 (enExample)
KR (1) KR20230131182A (enExample)
CN (1) CN116829141A (enExample)
AU (1) AU2021400215A1 (enExample)
CA (1) CA3202461A1 (enExample)
CL (1) CL2023001737A1 (enExample)
CO (1) CO2023007903A2 (enExample)
IL (1) IL303751A (enExample)
MX (1) MX2023006728A (enExample)
WO (1) WO2022130288A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022022437A2 (pt) 2020-05-07 2023-01-03 Adorx Therapeutics Ltd Antagonistas do receptor a2a de adenosina
US20260048034A1 (en) 2024-08-15 2026-02-19 New Frontier Labs, Llc Compositions and methods for enhancing the efficacy of dicarboxylic acid esters, and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS539788A (en) * 1976-07-14 1978-01-28 Syntex Inc 55aloyll1*22dihydroo3hh pyroro *1*22a* pyroll11 carboxylic acid derivative
JPH07116026B2 (ja) * 1987-07-07 1995-12-13 株式会社資生堂 ジクロフェナックナトリウム含有乳化外用剤
JP2523428B2 (ja) * 1992-12-04 1996-08-07 エスエス製薬株式会社 消炎鎮痛ゲル製剤
US9265725B2 (en) * 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
JP2004300113A (ja) * 2003-04-01 2004-10-28 Nichiban Co Ltd 消炎鎮痛貼付剤
WO2006074379A2 (en) * 2005-01-07 2006-07-13 Azaya Therapeutics, Inc. Methods and compositions involving esters of azelaic acid and other dicarboxylic acids
US8822509B2 (en) * 2006-12-29 2014-09-02 The University Of Queensland Pain-relieving compositions and uses therefor
EP2219633A2 (en) * 2007-11-23 2010-08-25 Nectid, Inc. Tapentadol compositions
US20090326069A1 (en) * 2008-06-30 2009-12-31 Bltn, Llc Azelaic acid ester compositions and methods for diagnosing and treating tissue conditions using azelaic acid ester compositions and proteinaceous biomarkers
BRPI0901758A2 (pt) * 2009-05-28 2011-01-25 Cristalia Prod Quimicos Farm uso de telocinobufagina como analgésico no tratamento das dores aguda e crÈnica; composição farmacêutica contendo telocinobufagina e uso da mesma
US20120251525A1 (en) * 2009-06-30 2012-10-04 Streeper Robert T Method of utilizing azelaic acid esters to modulate communications mediated by biological molecules
EP3445354B8 (en) * 2016-04-20 2022-07-06 New Frontier Labs, LLC Azelaic acid esters in the treatment of insulin resistance
US20220023423A1 (en) * 2018-12-19 2022-01-27 Medrx Co., Ltd. Anti-Inflammatory Analgesic External Preparation
CN111544381B (zh) * 2020-05-12 2021-07-16 普霖贝利生物医药研发(上海)有限公司 一种包含壬二酸的皮肤局部给药组合物

Similar Documents

Publication Publication Date Title
JPWO2023027198A5 (enExample)
HRP20210928T1 (hr) Soli ili ko-kristali 3- (3-dimetilamino-1-etil-2-metil-propil)-fenola
JP2023017050A5 (enExample)
JP2008543854A5 (enExample)
JP2013532668A5 (enExample)
JP2021525787A5 (enExample)
JP2004526745A5 (enExample)
JPH08510479A (ja) 眼の炎症障害を処置するための３‐ベンゾイルフェニル酢酸誘導体を含む局所的に投与可能な組成物
JP2014507429A (ja) 心血管疾患の治療のための組成物および方法
HRP20170997T1 (hr) Asimetrične uree i njihove medicinske uporabe
HRP20240173T1 (hr) Fluorofenil beta-hidroksietilamini i njihova upotreba u liječenju hiperglikemije
JP2009543857A (ja) イブプロフェンの正荷電水溶性プロドラッグ
ES2846003T3 (es) Procedimientos para tratar afecciones pruriginosas mediadas por receptores de histamina H-4
JP2014505017A5 (enExample)
JP2015531376A5 (enExample)
JP2009504774A5 (enExample)
JP2024544415A5 (enExample)
JP2023533289A5 (enExample)
HRP20151138T1 (hr) Dihidroetorfini i njihovo pripremanje
JP2012526090A (ja) Ａｖｅ８０６２およびソラフェニブを含む抗腫瘍の組み合わせ
RU2019101226A (ru) Ингибиторы wnt для применения при лечении фиброза
JP2009506978A5 (enExample)
US20170319519A1 (en) Combination for the treatment of conditions involving muscular pain
JP2014520867A (ja) ジクロフェナクおよびチオコルチコシドを含有する貼付剤
RU2013157834A (ru) Композиции для подкожного введения физиологически активных средств